Drug trial for Alzheimer’s disease is a game changer

Eric M. Reiman ()

Nature, 2023, vol. 615, issue 7950, 42-43

Abstract: An antibody treatment reduces measurements of brain abnormalities called amyloid plaques in people with Alzheimer’s disease, and lessens clinical decline. This result will help in developing therapies to treat and prevent the disease.

Keywords: Alzheimer's disease; Medical research; Neurodegeneration (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-023-00393-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:615:y:2023:i:7950:d:10.1038_d41586-023-00393-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-023-00393-7

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().